Respiratory Syncytial Virus Vaccine Market to Surpass USD 15.9 Billion by 2035, Growing at 13.8% CAGR | By TMR
Respiratory Syncytial Virus Vaccine Market to reach US$ 15.9 Bn by 2035, growing at 13.8% CAGR, driven by rising RSV cases and vaccine adoption worldwide. WILMINGTON, DE, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- The respiratory syncytial …